<DOC>
	<DOCNO>NCT02787473</DOCNO>
	<brief_summary>To evaluate efficacy toxicity patient inoperable squamous cell lung cancer treat pemetrexed plus cisplatin concurrent radiation therapy follow docetaxel consolidation . An exploratory biomarker analysis blood tumor sample also plan .</brief_summary>
	<brief_title>A Study Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed Docetaxel Consolidation Patients With Inoperable Squamous Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Newly diagnose stage IIIA/ IIIB squamous cell lung cancer ; All sit disease must amenable definitive radiotherapy ; Age 18 year 75 year ; Eastern Cooperative Oncology Group ( ECOG ) Performance Status 02 ; Forced expiratory volume 1 second ( FEV1 ) &gt; 0.75L ; No previous chest radiotherapy , immunotherapy biotherapy ; Adequate bone marrow , liver renal function , specify : Absolute Neutrophil Count ( ANC ) ≥ 1.5 x 109/L ; Hemoglobin ≥ 8 g/dL ; Platelets ≥ 100 x 109/L ; Serum total bilirubin ≤ 1.5 x upper limit normal ( ULN ) ; Aspartate transaminase ( AST ) alanine Transaminase ( ALT ) ≤ 2.5 x ULN ≤ 5 x ULN liver metastases present ; Serum creatinine ≤ 1.5 x upper limit normal creatinine clearance ≥ 60ml/min patient creatinine level institutional normal . For woman childbearing potential , negative pregnancy test within 14 day prior start treatment Men woman childbearing age must willing use effective contraception treatment least 3 month thereafter ; Patients family sign informed consent ; Active infection ; History significant cardiac disease ( unstable angina , congestive heart failure , myocardial infarction within previous 6 month , ventricular arrhythmia ) ; Malnutrition ( loss ≥ 20 % original body weight ) ; Performance status : 34 ; Sensor motor neuropathy &gt; grade I ; Second primary malignancy , except nonmelanoma skin cancer ; Psychiatric illness social situation would preclude study compliance ; Pregnant lactate woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Squamous cell lung cancer</keyword>
	<keyword>Pemetrexed</keyword>
	<keyword>Radiosensitivity</keyword>
</DOC>